Nancy Veulemans
Geen lopende functies
Profiel
Nancy Veulemans formerly worked at ClinTrials Research, Inc., as Principal, BruCells NV, as Head-Regulatory Affairs from 2005 to 2012, Cyanamid International Corp., as Product Manager, and Bristol Myers International Group, as Principal.
Ms. Veulemans received her graduate degree from Université Catholique de Louvain.
Eerdere bekende functies van Nancy Veulemans
| Bedrijven | Functie | Einde |
|---|---|---|
BruCells NV
 BruCells NV Pharmaceuticals: MajorHealth Technology BruCells NV develops therapeutic vaccines against cancer. The company was founded in 2001 and is headquartered in Brussels, Belgium. | Algemeen Adviseur | 22-11-2012 |
| Cyanamid International Corp. | Corporate Officer/Principal | - |
ClinTrials Research, Inc.
 ClinTrials Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marvell Technology, Inc., ClinTrials Research, Inc. engages in clinical research organization. The company is based in Cary, NC. ClinTrials Research was acquired by Indigo Acquisition Corp on April 03, 2001 for $110.42 million. | Corporate Officer/Principal | - |
| Bristol Myers International Group | Corporate Officer/Principal | - |
Opleiding van Nancy Veulemans
| Université Catholique de Louvain | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
BruCells NV
BruCells NV Pharmaceuticals: MajorHealth Technology BruCells NV develops therapeutic vaccines against cancer. The company was founded in 2001 and is headquartered in Brussels, Belgium. | Health Technology |
| Bristol Myers International Group | |
ClinTrials Research, Inc.
ClinTrials Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Marvell Technology, Inc., ClinTrials Research, Inc. engages in clinical research organization. The company is based in Cary, NC. ClinTrials Research was acquired by Indigo Acquisition Corp on April 03, 2001 for $110.42 million. | Commercial Services |
| Cyanamid International Corp. |
